First National Advisers’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$469K Buy
3,651
+675
+23% +$79K 0.07% 181
2026
Q1
$358K Sell
2,976
-1,020
-26% -$118K 0.05% 192
2025
Q4
$421K Sell
3,996
-516
-11% -$48.4K 0.06% 176
2025
Q3
$379K Sell
4,512
-1,701
-27% -$140K 0.05% 190
2025
Q2
$492K Sell
6,213
-7,387
-54% -$587K 0.07% 168
2025
Q1
$1.22M Sell
13,600
-8,751
-39% -$817K 0.2% 125
2024
Q4
$2.22M Sell
22,351
-3,802
-15% -$392K 0.36% 88
2024
Q3
$2.97M Buy
26,153
+1,416
+6% +$168K 0.47% 66
2024
Q2
$3.06M Buy
24,737
+4,991
+25% +$643K 0.56% 56
2024
Q1
$2.51M Buy
19,746
+5,604
+40% +$691K 0.56% 55
2023
Q4
$1.54M Buy
14,142
+1,969
+16% +$204K 0.44% 76
2023
Q3
$1.25M Buy
12,173
+8,518
+233% +$918K 0.56% 61
2023
Q2
$422K Sell
3,655
-220
-6% -$25K 0.39% 80
2023
Q1
$412K Buy
3,875
+297
+8% +$32.1K 0.47% 77
2022
Q4
$397K Sell
3,578
-680
-16% -$69.5K 0.51% 79
2022
Q3
$367K Buy
4,258
+861
+25% +$76.9K 0.54% 73
2022
Q2
$310K Buy
+3,397
New +$301K 0.64% 67

Other funds holding MRK

First National Advisers's MRK Position: Q2 2026 in Review

First National Advisers increased its Merck (MRK) stake by 23% in Q2 2026, buying an estimated $79K and bringing the position to 3,651 shares worth $469K. The position accounts for 0.07% of the portfolio, ranked #181.

First National Advisers first reported a position in MRK in Q2 2022 and has held it in 17 quarters since. The position peaked at $3.06M in Q2 2024. 1,752 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • First National Advisers held 3,651 shares of Merck worth $469K as of Q2 2026.
  • First National Advisers bought 675 Merck shares in Q2 2026, an estimated $79K.
  • Merck made up 0.07% of First National Advisers's portfolio in Q2 2026, its #181 holding.
  • First National Advisers first reported a position in Merck in Q2 2022 and has held it in 17 quarters since.
  • First National Advisers's Merck position peaked at $3.06M in Q2 2024.
  • 1,752 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on First National Advisers's 13F filing for Q2 2026, filed 21 Jul 2026.